Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 95,390 | 141,446 | 105,957 | 80,020 | 32,868 |
| Operating Income | -95,390 | -141,446 | -105,957 | -80,020 | -32,868 |
| Other Income | 4,417 | 117,104 | 8,740 | 3,774 | 483 |
| Pre-tax Income | -90,973 | -24,342 | -97,217 | -76,246 | -32,385 |
| Net Income Continuous | -90,973 | -24,342 | -97,217 | -76,246 | -32,385 |
| Net Income | $-90,973 | $-24,342 | $-97,217 | $-76,246 | $-32,385 |
| EPS Basic Total Ops | -1.88 | -0.53 | -2.32 | -1.90 | -0.82 |
| EPS Basic Continuous Ops | -1.88 | -0.53 | -2.32 | -1.90 | -0.82 |
| EPS Diluted Total Ops | -1.88 | -1.46 | -2.32 | -1.90 | -0.82 |
| EPS Diluted Continuous Ops | -1.88 | -0.52 | -2.32 | -1.90 | -0.82 |
| EPS Diluted Before Non-Recurring Items | -1.88 | -3.78 | -2.32 | -1.90 | -0.82 |
| EBITDA(a) | $-94,454 | $-140,314 | $-104,427 | $-78,719 | $-32,334 |